Selection of breast cancer patients for an aromatase inhibitor after radiation and tamoxifen

被引:0
|
作者
Freedman, GM [1 ]
Anderson, P [1 ]
Li, T [1 ]
Ross, E [1 ]
Swaby, R [1 ]
Goldstein, L [1 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词
D O I
10.1016/j.ijrobp.2005.07.413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2019
引用
收藏
页码:S242 / S242
页数:1
相关论文
共 50 条
  • [21] Perioperative Aromatase Inhibitor Therapy for Patients with Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (02) : 114 - +
  • [22] Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
    Hadji, Peyman
    BREAST CARE, 2010, 5 (05) : 290 - 296
  • [23] Breast cancer: Aromatase inhibitors take on tamoxifen
    Mitch Dowsett
    Anthony Howell
    Nature Medicine, 2002, 8 : 1341 - 1344
  • [24] The need for DXA assessment of breast cancer patients following 5 years tamoxifen prior to starting an aromatase inhibitor
    Brown, L.
    Whannel, K. J.
    McLennan, A.
    Wilson, C. R.
    Doughty, J. C.
    CANCER RESEARCH, 2009, 69 (02) : 390S - 390S
  • [25] Is an aromatase inhibitor more effective than tamoxifen in neoadjuvant endocrine therapy for breast cancer?
    Roukos, DH
    Fatouros, M
    Paraskevaidis, E
    Kappas, AM
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (02): : 82 - 83
  • [26] Is an aromatase inhibitor more effective than tamoxifen in neoadjuvant endocrine therapy for breast cancer?
    Dimitrios H Roukos
    Michael Fatouros
    Evangelos Paraskevaidis
    Angelos M Kappas
    Nature Clinical Practice Oncology, 2006, 3 : 82 - 83
  • [27] Efficacy of Exemestane after Nonsteroidal Aromatase Inhibitor Use in Metastatic Breast Cancer Patients
    Kim, Sun Hye
    Park, In Hae
    Lee, Hyewon
    Lee, Keun Seok
    Nam, Byung-Ho
    Ro, Jungsil
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) : 979 - 983
  • [28] Postmenopausal advanced breast cancer: Options for therapy after tamoxifen and aromatase inhibitors
    Dodwell, D.
    Wardley, A.
    Johnston, S.
    BREAST, 2006, 15 (05): : 584 - 594
  • [29] Endocrine therapy after aromatase inhibitor therapy in breast cancer
    Verma, Mohit K.
    Miki, Yasuhiro
    Sasano, Hironobu
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (03) : 309 - 312
  • [30] Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors
    Sestak, Ivana
    Cuzick, Jack
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 425 - 432